B-CELL NON-HODGKIN LYMPHOMA (B-NHL)
Clinical trials for B-CELL NON-HODGKIN LYMPHOMA (B-NHL) explained in plain language.
Never miss a new study
Get alerted when new B-CELL NON-HODGKIN LYMPHOMA (B-NHL) trials appear
Sign up with your email to follow new studies for B-CELL NON-HODGKIN LYMPHOMA (B-NHL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial offers hope for Tough-to-Treat lymphoma
Disease control Recruiting nowThis study is testing an experimental drug called odronextamab for people with an aggressive type of blood cancer (B-cell non-Hodgkin lymphoma) that has come back or stopped responding to their first treatment. The main goal is to see if this new drug works better and is as safe …
Matched conditions: B-CELL NON-HODGKIN LYMPHOMA (B-NHL)
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC
-
New Two-Pronged immune cell therapy tested for Tough-to-Treat lymphomas
Disease control Recruiting nowThis early-stage trial is testing the safety and finding the right dose of a new type of CAR-T cell therapy for people whose B-cell non-Hodgkin lymphoma has come back or hasn't responded to other treatments. The therapy uses a patient's own modified immune cells designed to attac…
Matched conditions: B-CELL NON-HODGKIN LYMPHOMA (B-NHL)
Phase: PHASE1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Feb 24, 2026 14:08 UTC